Major factor driving growth of the global leucine market is growing demand from athletes for products with high leucine content. In addition, growing demand from food & beverage and pharmaceutical sector, owing to various benefits offered by leucine such as enhanced fat loss, improved muscle recovery, better physical performance, decreased muscle loss, and better blood sugar control is another factor expected to support growth of the global market to certain extent.
The global leucine market report has been segmented on the basis of source, application, end-use industries, and region.
The source segment in the global target market is segmented on the basis of animal and plant. The animal segment is expected to contribute significant revenue share in the global market.
The application segment in the global target market is segmented on the basis of food additive and flavor enhancer. The food additive segment is expected to contribute significant revenue share in the global market.
The end-use industries segment in the global target market is segmented on the basis of food & beverages, pharmaceuticals cosmetics, and agriculture/animal feed. The food & beverage segment is expected to contribute significant revenue share in the global market.
Request For The Sample Report Here: https://marketresearch.biz/report/leucine-market/request-sample/
On the basis of region, the global target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America is expected to dominate the global market and is expected to continue its dominance over the forecast period. This can be attributed to growing merger and acquisition activities and increasing investment for R&D activates and novel product offerings by major players operating in the economies in this region. The markets in Latin America and Middle East & Africa are expected to witness moderate growth over the forecast period.
Key players operating in the target market include Ajinomoto Co. Inc., Kyowa Hakko Bio Co. Ltd., Evonik Industries AG, Wuxi Jinghai Amino Acid Co. Ltd., and Yichang Sanxia Pharmaceutical Co. Ltd.